Korro Bio, Inc.
KRRO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001703647
In the last 90 days, Korro Bio, Inc. insiders filed 1 open-market purchase and 7 sales; 106 institutions reported holding it in 13F filings for Q2 2026, worth $190.1M in total; no superinvestor holds it.
Q1 2023 vs. Q4 2022
How the institutions holding Korro Bio, Inc. changed between Q4 2022 and Q1 2023.
All holders in Q1 2023All holders in Q4 2022
| Measure | Q4 2022 | Q1 2023 | Change |
|---|---|---|---|
| Holders | 50 | 43 | −7 |
| Shares | 7.40M | 5.01M | −2.38M (−32.2%) |
| Value | $28.3M | $2.52M | −$25.8M (−91.1%) |
New holders (6)
Institutions that held Korro Bio, Inc. at the end of Q1 2023 but not at the end of Q4 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Acadian Asset Management LLC | 140,945 | $70.0K | 0.00% |
| Marshall Wace, LLP | 68,089 | $34.0K | 0.00% |
| Raymond James & Associates | 21,000 | $10.6K | 0.00% |
| Spire Wealth Management | 1,972 | $986 | 0.00% |
| The PNC Financial Services Group, Inc. | 1,000 | $503 | 0.00% |
| Orion Capital Management LLC | 1,000 | $503 | 0.00% |
Sold out (13)
Institutions that held Korro Bio, Inc. at the end of Q4 2022 and filed for Q1 2023 without it.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| Federated Hermes, Inc. | 1,311,580 | $5.05M |
| Wasatch Advisors Inc | 752,973 | $2.90M |
| Gsa Capital Partners LLP | 264,728 | $1.02M |
| Dimensional Fund Advisors LP | 52,076 | $200.0K |
| Goldman Sachs Group Inc | 42,925 | $165.3K |
| Ergoteles LLC | 25,555 | $98.4K |
| Neuberger Berman Group LLC | 20,000 | $77.0K |
| Centaurus Financial, Inc. | 17,400 | $67.0K |
| Cubic Asset Management, LLC | 11,000 | $42.4K |
| Barclays PLC | 10,587 | $40.8K |
| Jane Street Group, LLC | 10,029 | $38.6K |
| Tortoise Investment Management, LLC | 10,000 | $38.5K |
| FMR LLC | 553 | $2.13K |